Advanced cardiac imaging in athlete’s heart: unravelling the grey zone between physiologic adaptation and pathology

Palmisano, Anna; Darvizeh, Fatemeh; Cundari, Giulia; Rovere, Giuseppe; Ferrandino, Giovanni; Nicoletti, Valeria; Cilia, Francesco; Vizio, Silvia De; Palumbo, Roberto; Esposito, Antonio; Francone, Marco

doi:10.1007/s11547-021-01411-2

Cited by 19 publications

(35 citation statements)

References 98 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Different diagnostic tools may be employed, alone or in association [ 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 ]. Computed tomography (CT) and magnetic resonance imaging (MRI) represent the traditional imaging tools employed during the pre-treatment phase in order to identify and assess the target area [ 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 ], and in surveillance of the patient to evaluate treatment efficacy and post-procedural complications [ 87 , 88 , 89 , 90 , 91 , 92 , 93 ]. Ultrasound examination (US), without or with contrast medium (CEUS), is an innovative tool, utilized for problem solving during pre- and post-treatment phases [ 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 ], although the main use of interest is the possibility of assessing immediate effects during the procedure [ 60 , 61 ].…”

Section: Imaging and Ablation Treatmentmentioning

confidence: 99%

Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect

Granata

Fusco

Muzio

et al. 2022

JCM

View full text Add to dashboard Cite

One of the major fields of application of ablation treatment is liver tumors. With respect to HCC, ablation treatments are considered as upfront treatments in patients with early-stage disease, while in colorectal liver metastases (CLM), they can be employed as an upfront treatment or in association with surgical resection. The main prognostic feature of ablation is the tumor size, since the goal of the treatment is the necrosis of all viable tumor tissue with an adequate tumor-free margin. Radiofrequency ablation (RFA) and microwave ablation (MWA) are the most employed ablation techniques. Ablation therapies in HCC and liver metastases have presented a challenge to radiologists, who need to assess response to determine complication-related treatment. Complications, defined as any unexpected variation from a procedural course, and adverse events, defined as any actual or potential injury related to the treatment, could occur either during the procedure or afterwards. To date, RFA and MWA have shown no statistically significant differences in mortality rates or major or minor complications. To reduce the rate of major complications, patient selection and risk assessment are essential. To determine the right cost-benefit ratio for the ablation method to be used, it is necessary to identify patients at high risk of infections, coagulation disorders and previous abdominal surgery interventions. Based on risk assessment, during the procedure as part of surveillance, the radiologists should pay attention to several complications, such as vascular, biliary, mechanical and infectious. Multiphase CT is an imaging tool chosen in emergency settings. The radiologist should report technical success, treatment efficacy, and complications. The complications should be assessed according to well-defined classification systems, and these complications should be categorized consistently according to severity and time of occurrence.

show abstract

Section: Imaging and Ablation Treatmentmentioning

confidence: 99%

Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect

Granata

Fusco

Muzio

et al. 2022

JCM

View full text Add to dashboard Cite

show abstract

“…Extra-cellular volume (ECV), on the other hand, allows the quantification of extracellular matrix (as percentage), whose expansion can result from edema, fibrosis, or storage disease. Moreover, recent evidence suggests that ECV allows the quantification of different myofibrillar and interstitial matrix compositions, which is also useful in the discrimination between different hypertrophic phenotypes [ 112 ].…”

Section: Cmr and Ccta Imagingmentioning

confidence: 99%

Heart Failure and Cardiomyopathies: CT and MR from Basics to Advanced Imaging

Palumbo

Cannizzaro²,

Palumbo

et al. 2022

Diagnostics

View full text Add to dashboard Cite

Since 1997, heart failure (HF) has been designated as a new epidemic. However, it is not easy to find a proper definition since different descriptors are used in clinical practice. Moreover, HF is not a single clinical entity, and there is a close relationship between HF and all cardiomyopathies (CMs). This leads us to also consider accuracy in the characterization of CMs, which is essential to define the therapeutic process of HF patients. This narrative review aims to describe the main mechanisms leading to HF in different CMs, as well as the current diagnostic and prognostic advantages deriving from advanced imaging in the cardiac field.

show abstract

“…Through the pulmonary circulation, this high left atrial pressure builds up, causing the right ventricle afterload elevation. Right ventricular dilation is determined by the increased right ventricle afterload [ 24 ].…”

Section: Reviewmentioning

confidence: 99%

Sudden Cardiac Arrest in Athletes: A Primary Level of Prevention

Prakash¹,

Swarnakari²,

Bai³

et al. 2022

Cureus

View full text Add to dashboard Cite

Primary prevention of sudden cardiac arrest (SCA) refers to the use of pharmacological or interventional therapy and healthy lifestyle modifications to prevent sudden cardiac death (SCD) in patients who have not experienced symptomatic, life-threatening persistent ventricular tachycardia or ventricular fibrillation or SCA but are considered to be at a higher risk. This review provides an overview of the physiological heart changes and distinct electrical manifestations, the etiology of SCA, and screening methods and interventions for the prevention of SCA in athletes. The American College of Cardiology and the American Heart Association (AHA) Guidelines recommend screening with a 14-point history and physical examination. In most cases, a thorough clinical evaluation along with an ECG is sufficient for screening. Athletes with heart diseases leading to SCD are urged not to compete. Further decisions are taken following the European Society of Cardiology and the AHA's current workout recommendations. Early detection of cardiac disease allows for individualized risk evaluation and treatment, which has been shown to reduce mortality rates in athletes.

show abstract

Advanced cardiac imaging in athlete’s heart: unravelling the grey zone between physiologic adaptation and pathology

Cited by 19 publications

References 98 publications

Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect

Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect

Heart Failure and Cardiomyopathies: CT and MR from Basics to Advanced Imaging

Sudden Cardiac Arrest in Athletes: A Primary Level of Prevention

Contact Info

Product

Resources

About